DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Asset Reconstruction Company (India) Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 11:53 am

Asset Reconstruc CO (I) L

Asset Reconstruction Company (India) Limited (ARCIL) has informed the stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations for the quarter ending September 30, 2026. This document confirms that the company has complied with all necessary regulatory requirements regarding its depository operations and investor protection measures.

For investors, this filing is a routine procedural update that ensures the company's compliance with market regulations. It serves as a confirmation that ARCIL is adhering to the governance standards set by the Securities and Exchange Board of India. While this specific news does not alter the company's core business operations, it reinforces the firm's commitment to regulatory transparency.

Investors should monitor the company's upcoming quarterly results and credit recovery trends. The focus should remain on ARCIL's asset quality and the performance of its portfolio, as these factors are more critical for the stock's valuation than routine regulatory filings.